High intake of dietary advanced glycation end products, which have been linked to Alzheimer's disease and metabolic syndrome, are associated with cognitive and motor deficits and insulin resistance in mice and humans, according to a study published online Feb. 24 in the Proceedings of the National Academy of Sciences.
In patients with amyotrophic lateral sclerosis, a high-calorie, enteral diet is safe and tolerable and improves survival, according to a small study published online Feb. 28 in The Lancet.
Stethoscopes get contaminated after a single physical exam, with the contamination greater than that seen on most of the physician's dominant hand, barring the fingertips, according to a study published online Feb. 27 in the Mayo Clinic Proceedings.
Use of hormonal contraceptives may be contributing to the increasing incidence of multiple sclerosis in women, according to a study released in advance of the annual meeting of the American Academy of Neurology, which will be held from April 26 to May 3 in Philadelphia.
Examining evidence from epidemiologic, clinical, and animal studies, a team of researchers discussed the connection between neural dysfunction and metabolic disorders related to type 2 diabetes in the February 2014 issue of Current Diabetes Reports.
Size and market share are the greatest differentiators between hospitals receiving low prices and high prices for inpatient care, according to a study published in the February issue of Health Affairs.
Researchers identify several independent risk factors for the development of severe and/or symptomatic hyponatremia in patients on oxcarbazepine therapy.
Most people with nonvalvular atrial fibrillation should be taking oral anticoagulants to prevent stroke, according to an American Academy of Neurology guideline published in the Feb. 25 issue of Neurology.
Data for quality measures have been added to Physician Compare, the website that helps consumers search for information about physicians, according to a report published by the Centers for Medicare & Medicaid Services.
The US Food and Drug Administration is to increase monitoring of drugs from pharmaceutical companies in India, FDA Commissioner Margaret Hamburg, MD, said during a Friday afternoon news conference.